跳至主要内容
临床试验/NCT02841072
NCT02841072已完成不适用

Chart Review Study of Medical Abortion at 64-70 Days of Gestation

Gynuity Health Projects2 个研究点 分布在 1 个国家目标入组 579 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
579
试验地点
2
主要终点
Abortion Success

研究概览

简要总结

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal misoprostol at 64-70 days of gestation.

详细描述

The study will be conducted at US abortion clinics that have offered medical abortion with 200 mg mifepristone + 800 mcg buccal misoprostol to at least 20 women at 64-70 days of gestation. Designated staff at each site will review clinic records to identify and record data from every patient treated in that gestational week. Once data collection is completed, if the rate of success or serious complications at any clinic is substantially discordant from rates documented in the published literature, we may collect additional data on patients seeking medical abortion at 57-63 days, to aid in explaining results found in the 64-70 days group. In this situation, for each patient in the 64-70 days group, site staff will identify and record data from the next consecutive patient treated with this regimen at 57-63 days.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Women at 64-70 days of gestation
  • Received 200 mg mifepristone + 800 mcg buccal misoprostol for a medical abortion

排除标准

  • Does not meet the inclusion criteria

结局指标

主要结局

Abortion Success

时间窗: 1 week

Defined as a complete abortion without use of surgery

Serious complications

时间窗: 1 month

Defined as admission to hospital, receipt of parenteral antibiotics, surgery (laparoscopies, laparotomies, hysterectomies), transfusion, or death

次要结局

  • Proportion of complete abortions without additional treatment(1 week)
  • Proportion of ongoing pregnancies(1 week)
  • Proportion of significant abortion complications(1 month)

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验